Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127173031 | 12717303 | 1 | I | 201512 | 20160831 | 20160906 | 20160906 | EXP | FR-AFSSAPS-NT20161119 | FR-GLAXOSMITHKLINE-FR2016GSK127193 | GLAXOSMITHKLINE | 38.91 | YR | M | Y | 0.00000 | 20160906 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127173031 | 12717303 | 1 | PS | Wellvone | ATOVAQUONE | 1 | Oral | 750 MG, BID | Y | 20259 | 750 | MG | BID | ||||||
| 127173031 | 12717303 | 2 | SS | Malocide | PYRIMETHAMINE | 1 | Oral | 1 DF, QD | Y | 0 | 1 | DF | TABLET | QD | |||||
| 127173031 | 12717303 | 3 | SS | COUMADIN | WARFARIN SODIUM | 1 | Oral | 2 MG, QD | Y | 0 | 2 | MG | QD | ||||||
| 127173031 | 12717303 | 4 | SS | NORVIR | RITONAVIR | 1 | Oral | 1 DF, QD | Y | 0 | 1 | DF | QD | ||||||
| 127173031 | 12717303 | 5 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | 1 DF, QD | Y | 0 | 1 | DF | QD | ||||||
| 127173031 | 12717303 | 6 | C | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | UNK | U | 0 | FILM-COATED TABLET | ||||||||
| 127173031 | 12717303 | 7 | C | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | UNK | U | 0 | FILM-COATED TABLET | |||||||||
| 127173031 | 12717303 | 8 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | U | 0 | |||||||||||
| 127173031 | 12717303 | 9 | C | NICOTINE. | NICOTINE | 1 | Oral | U | 0 | LOZENGE | |||||||||
| 127173031 | 12717303 | 10 | C | PARACETAMOL | ACETAMINOPHEN | 1 | U | 0 | |||||||||||
| 127173031 | 12717303 | 11 | C | PRAVASTATIN. | PRAVASTATIN | 1 | U | 0 | |||||||||||
| 127173031 | 12717303 | 12 | C | Tiorfan | RACECADOTRIL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127173031 | 12717303 | 1 | Toxoplasmosis prophylaxis |
| 127173031 | 12717303 | 2 | Toxoplasmosis prophylaxis |
| 127173031 | 12717303 | 3 | Phlebitis |
| 127173031 | 12717303 | 4 | HIV infection |
| 127173031 | 12717303 | 5 | HIV infection |
| 127173031 | 12717303 | 6 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127173031 | 12717303 | LT |
| 127173031 | 12717303 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127173031 | 12717303 | Pancytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127173031 | 12717303 | 1 | 20150609 | 20151215 | 0 | |
| 127173031 | 12717303 | 2 | 20150609 | 20151215 | 0 | |
| 127173031 | 12717303 | 3 | 20151203 | 201512 | 0 | |
| 127173031 | 12717303 | 4 | 20150326 | 20151215 | 0 | |
| 127173031 | 12717303 | 5 | 20150326 | 20151215 | 0 | |
| 127173031 | 12717303 | 6 | 20150326 | 20151215 | 0 | |
| 127173031 | 12717303 | 7 | 201601 | 0 |